Who owns SYRE? 13F holders and whale ownership
SYRE is tracked across public portfolios in Whale Analyzer. This page answers who owns SYRE, which top funds are buying SYRE, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $190.8M | 3.8M | Increased |
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $81.8M | 1.6M | Held |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $50.4M | 1.0M | Held |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- PRAX whale holders — PRAXIS PRECISION MEDICINES I
- CELC whale holders — CELCUITY INC
- ASND whale holders — ASCENDIS PHARMA A/S
- ROIV whale holders — ROIVANT SCIENCES LTD
- CNTA whale holders — CENTESSA PHARMACEUTICALS PLC
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- NUVL whale holders — NUVALENT INC
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns SYRE stock?
Whale Analyzer tracks 3 public institutional holders of SYRE with a combined reported value of $323.1M. See the holder table above for the largest tracked positions.
Which top funds are buying SYRE?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for SYRE?
Use the interactive SYRE dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.